HFS
PCRX icon

HL Financial Services’s Pacira BioSciences PCRX Stock Holding History

HL Financial Services’s Portfolio PCRX Stock Details PCRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-5,651
Closed -$502K – 677
2015
Q1 		$502K Sell
5,651
-541
-9% -$54.9K 0.01% 459
2014
Q4 		$549K Sell
6,192
-675
-10% -$63.8K 0.02% 409
2014
Q3 		$666K Sell
6,867
-67
-1% -$6.52K 0.02% 347
2014
Q2 		$637K Hold
6,934
– – 0.02% 361
2014
Q1 		$485K Sell
6,934
-1,506
-18% -$102K 0.01% 406
2013
Q4 		$485K Sell
8,440
-577
-6% -$30.3K 0.01% 388
2013
Q3 		$433K Buy
+9,017
New +$329K 0.02% 386

Other funds holding PCRX

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
GGHC
Gilder Gagnon Howe & Co New York $9.69B AUM 55.7% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
MCM
Marsico Capital Management Denver, Colorado $3.83B AUM 63.68% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

HL Financial Services's PCRX Position: Q2 2015 in Review

HL Financial Services sold out of Pacira BioSciences (PCRX) in Q2 2015, closing a stake of 5,651 shares — an estimated $502K sold.

HL Financial Services first reported a position in PCRX in Q3 2013 and held it in 7 quarters. The position peaked at $666K in Q3 2014. 187 funds tracked by Wall St. Rank hold PCRX as of Q2 2015.

  • HL Financial Services reported no remaining Pacira BioSciences position as of Q2 2015 after selling out during the quarter.
  • HL Financial Services sold 5,651 Pacira BioSciences shares in Q2 2015, an estimated $502K.
  • HL Financial Services first reported a position in Pacira BioSciences in Q3 2013 and held it in 7 quarters.
  • HL Financial Services's Pacira BioSciences position peaked at $666K in Q3 2014.
  • 187 funds tracked by Wall St. Rank held Pacira BioSciences as of Q2 2015.

Based on HL Financial Services's 13F filing for Q2 2015, filed 28 Jul 2015.